Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-07-002548
Filing Date
2007-03-22
Accepted
2007-03-22 16:10:56
Documents
21
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 PHARMANET DEVELOPMENT GROUP, INC. g05916e10vk.htm 10-K 1498792
2 EX-3.4 SECOND AMENDMENT TO CERTIFICATE OF INCORPORATION g05916exv3w4.htm EX-3.4 5587
3 EX-3.7 THIRD AMENDMENT TO CERTIFICATE OF INCORPORATION g05916exv3w7.htm EX-3.7 4009
4 EX-4.1 FORM OF COMMON STOCK CERTIFICATE g05916exv4w1.htm EX-4.1 13591
5 EX-10.2 DAVID NATAN EMPLOYMENT AGREEMENT g05916exv10w2.htm EX-10.2 80174
6 EX-10.16 AMENDED AND RESTATED 1999 STOCK PLAN g05916exv10w16.htm EX-10.16 61000
7 EX-10.18 AUDIT COMMITTEE CHARTER g05916exv10w18.htm EX-10.18 21441
8 EX-10.29 THOMAS J. NEWMAN, MD EMPLOYMENT AGREEMENT g05916exv10w29.htm EX-10.29 79890
9 EX-10.37 FORM OF DIRECTOR INDEMNIFICATION AGREEMENT g05916exv10w37.htm EX-10.37 45116
10 EX-10.38 FORM OF EXECUTIVE OFFICER INDEMNIFICATION AGREEMENT g05916exv10w38.htm EX-10.38 45477
11 EX-10.39 FORM OF DIRECTOR RESTRICTED STOCK UNIT AGREEMENT g05916exv10w39.htm EX-10.39 38523
12 EX-10.40 FORM OF EMPLOYEE RESTRICTED STOCK UNIT AGREEMENT g05916exv10w40.htm EX-10.40 43166
13 EX-10.41 JOHN P. HAMILL EMPLOYMENT AGREEMENT g05916exv10w41.htm EX-10.41 84613
14 EX-21 SUBSIDIARIES OF PHARMANET DEVELOPMENT GROUP, INC. g05916exv21.htm EX-21 11958
15 EX-23.1 CONSENT OF GRANT THORNTON LLP g05916exv23w1.htm EX-23.1 1992
16 EX-31.1 SECTION 302 CERTIFICATION OF CEO g05916exv31w1.htm EX-31.1 8566
17 EX-31.2 SECTION 302 CERTIFICATION OF CFO g05916exv31w2.htm EX-31.2 8513
18 EX-32.1 SECTION 906 CERTIFICATION OF CEO g05916exv32w1.htm EX-32.1 3861
19 EX-32.2 SECTION 906 CERTIFICATION OF CFO g05916exv32w2.htm EX-32.2 3968
20 GRAPHIC g05916g0591600.gif GRAPHIC 10699
21 GRAPHIC g05916g0591601.gif GRAPHIC 325823
  Complete submission text file 0000950144-07-002548.txt   2525722
Mailing Address 504 CARNEGIE CENTER PRINCETON NJ 08540-6242
Business Address 504 CARNEGIE CENTER PRINCETON NJ 08540-6242 609-951-6800
PharmaNet Development Group Inc (Filer) CIK: 0001089542 (see all company filings)

EIN.: 592407464 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16119 | Film No.: 07712095
SIC: 8731 Services-Commercial Physical & Biological Research